Clinical and densitometric efficacy of the association of interferon alpha and pamidronate in the treatment of osteoporosis in patients with systemic mastocytosis

Author： Laroche M.   Bret J.   Brouchet A.   Mazières B.  

Publisher： Springer Publishing Company

ISSN： 0770-3198

Source： Clinical Rheumatology, Vol.26, Iss.2, 2007-02, pp. : 242-243

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Treatment of systemic mastocytosis

By Marrache F.   Memain N.   Bonte I.   Barete S.   Casassus P.   de Gennes C.   Fain O.   Hermine O.   Lortholary O.  

La Revue de Medecine Interne, Vol. 24, Iss. 9, 2003-09 ,pp. : 594-601

Elsevier

Access to resources Recommend Favorite

Systemic mastocytosis presenting as osteoporosis—a case report

By Mathew R.   Dhillon V.   Shepherd P.  

Clinical Rheumatology, Vol. 28, Iss. 7, 2009-07 ,pp. : 865-866

Springer Publishing Company

Access to resources Recommend Favorite

Risedronate and Pamidronate Treatment in the Clinical Management of Patients with Severe Paget’s Disease of Bone and Acquired Resistance to Bisphosphonates

By Rendina D.  

Calcified Tissue International, Vol. 75, Iss. 3, 2004-09 ,pp. : 189-196

Springer Publishing Company

Access to resources Recommend Favorite

Systemic Mastocytosis

By  

Digestive Diseases, Vol. 17, Iss. 5-6, 2000-06 ,pp. : 299-307

Karger

Access to resources Recommend Favorite

Clinical manifestations and antiphosphatidylserine antibodies in patients with systemic lupus erythematosus: is there an association?

By Sahin Mehmet   Duzgun Nursen   Tunc Sevket   Tutkak Huseyin  

Clinical Rheumatology, Vol. 26, Iss. 2, 2007-02 ,pp. : 154-160

Springer Publishing Company

Access to resources Recommend Favorite